GS-US-339-0103
Showing 1 - 25 of 7,331
Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- GS-0272
- Placebo
- (no location specified)
Sep 4, 2023
Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))
Enrolling by invitation
- Alcohol Consumption
- Control
- +2 more
-
Palo Alto, CaliforniaStanford University
May 8, 2023
Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)
Not yet recruiting
- Chronic Hepatitis B
- GS-2829
- +3 more
- (no location specified)
Mar 14, 2023
Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))
Not yet recruiting
- Genetic Predisposition
- Next-Generation Sequencing (NGS)
-
Tübingen, GermanyUniversity Hospital Tübingen
Sep 22, 2023
Gastroschisis Trial in Houston (fetoscopy)
Recruiting
- Gastroschisis
- fetoscopy
-
Houston, TexasTexas Children's Hospital
Jan 20, 2023
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
STEMI - ST Elevation Myocardial Infarction Trial
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- (no location specified)
Dec 24, 2022
HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)
Active, not recruiting
- HIV-1 Infection
- Oral Lenacapavir
- +3 more
-
Los Angeles, California
- +22 more
Nov 4, 2022
NASH - Nonalcoholic Steatohepatitis Trial in United States (HepQuant SHUNT Liver Diagnostic Kit)
Terminated
- NASH - Nonalcoholic Steatohepatitis
- HepQuant SHUNT Liver Diagnostic Kit
-
Miami, Florida
- +7 more
Aug 5, 2021
Ulcerative Colitis Trial in Naples (Filgotinib, Placebo)
Recruiting
- Ulcerative Colitis
- Filgotinib
- Placebo
-
Naples, FloridaGastroenterology Group of Naples
Aug 2, 2022
Stroke Trial in Venice (real tACS, sham tACS)
Recruiting
- Stroke
- real tACS
- sham tACS
-
Venice, ItalyIRCCS San Camillo Hospital
Apr 13, 2023
Sexual Health Trial in Taoyuan (Received the GS-SHEP)
Completed
- Sexual Health
- Received the GS-SHEP
-
Taoyuan, Guishan Dist., TaiwanCheng Gung Memorial Hospital
Mar 5, 2023
Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)
Terminated
- Cutaneous Lupus Erythematosus
- GS-5718
- Placebo
-
Beverly Hills, California
- +4 more
Nov 17, 2022
Prediabetic State, Overweight Trial (Verum A, Verum B, Placebo)
Not yet recruiting
- Prediabetic State
- Overweight
- Verum A
- +2 more
- (no location specified)
Jun 29, 2023
Ulcerative Colitis Trial in Worldwide (Filgotinib, PTM filgotinib)
HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)
Active, not recruiting
- HIV-1-infection
- Oral Lenacapavir
- +4 more
-
Los Angeles, California
- +74 more
Oct 17, 2022